Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Kidney Transplantation

  Free Subscription


Articles published in Nephrol Dial Transplant

Retrieve available abstracts of 73 articles:
HTML format
Text format



Single Articles


    November 2017
  1. HALIMI JM, Persu A, Sarafidis PA, Burnier M, et al
    Optimizing hypertension management in renal transplantation: a call to action.
    Nephrol Dial Transplant. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format    


    October 2017
  2. SANTOS AH JR, Chen C, Casey MJ, Womer KL, et al
    New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
    Nephrol Dial Transplant. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. NGUYEN KA, Syed JS, Luciano R, Shuch B, et al
    Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2 years too long to wait?
    Nephrol Dial Transplant. 2017;32:1767-1773.
    PubMed     Text format     Abstract available


  4. BRITT NS, Hagopian JC, Brennan DC, Pottebaum AA, et al
    Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation.
    Nephrol Dial Transplant. 2017;32:1758-1766.
    PubMed     Text format     Abstract available


    September 2017
  5. CHESNAYE NC, van Stralen KJ, Bonthuis M, Groothoff JW, et al
    The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplantation Association Registry study.
    Nephrol Dial Transplant. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. MALYSZKO J, Lopatowska P, Mlodawska E, Musialowska D, et al
    Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?
    Nephrol Dial Transplant. 2017 Sep 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. JOSHEE P, Wood AG, Wood ER, Grunfeld EA, et al
    Meta-analysis of cognitive functioning in patients following kidney transplantation.
    Nephrol Dial Transplant. 2017 Sep 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. HOWELL M, Yeo R, Tong A, Craig JC, et al
    Completeness of reporting of adverse events in trials of maintenance immunosuppression in kidney transplantation: a systematic review.
    Nephrol Dial Transplant. 2017;32:1586-1594.
    PubMed     Text format     Abstract available


    August 2017
  9. SHI X, Liu R, Xie X, Lv J, et al
    Effect of human leukocyte antigen mismatching on the outcomes of pediatric kidney transplantation: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. NEHUS EJ, Liu C, Lu B, Macaluso M, et al
    Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
    Nephrol Dial Transplant. 2017;32:1424-1431.
    PubMed     Text format     Abstract available


  11. HUH KH, Lee JG, Ha J, Oh CK, et al
    De novo low-dose sirolimus versus mycophenolate mofetil in combination with extended-release tacrolimus in kidney transplant recipients: a multicentre, open-label, randomized, controlled, non-inferiority trial.
    Nephrol Dial Transplant. 2017;32:1415-1424.
    PubMed     Text format     Abstract available


    July 2017
  12. ALLARD L, Kwon T, Krid S, Bacchetta J, et al
    Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort.
    Nephrol Dial Transplant. 2017 Jul 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. SNOWSILL TM, Moore J, Mujica Mota RE, Peters JL, et al
    Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation.
    Nephrol Dial Transplant. 2017;32:1251-1259.
    PubMed     Text format     Abstract available


    June 2017
  14. BUDDE K, Zeier M, Witzke O, Arns W, et al
    Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
    Nephrol Dial Transplant. 2017;32:1060-1070.
    PubMed     Text format     Abstract available


    May 2017
  15. MAURIELLO A, Rovella V, Borri F, Anemona L, et al
    Hypertension in kidney transplantation is associated with an early renal nerve sprouting.
    Nephrol Dial Transplant. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  16. WU DA, Robb ML, Watson CJ, Forsythe JL, et al
    Barriers to living donor kidney transplantation in the United Kingdom: a national observational study.
    Nephrol Dial Transplant. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. ZIEMANN M, Hessler N, Konig IR, Lachmann N, et al
    Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation.
    Nephrol Dial Transplant. 2017 Mar 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. VAN GELOVEN N, le Cessie S, Dekker FW, Putter H, et al
    Transplant as a competing risk in the analysis of dialysis patients.
    Nephrol Dial Transplant. 2017 Mar 3. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. WIRKEN L, van Middendorp H, Hooghof CW, Sanders JF, et al
    Pre-donation cognitions of potential living organ donors: the development of the Donation Cognition Instrument in potential kidney donors.
    Nephrol Dial Transplant. 2017;32:573-580.
    PubMed     Text format     Abstract available


    February 2017
  20. HAZELBAG CM, Peters SA, Blankestijn PJ, Bots ML, et al
    The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trials.
    Nephrol Dial Transplant. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. LEE J, Park JY, Huh KH, Kim BS, et al
    Rituximab and hepatitis B reactivation in HBsAg-negative/ anti-HBc-positive kidney transplant recipients.
    Nephrol Dial Transplant. 2017 Feb 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. ZECHER D, Bach C, Staudner C, Boger CA, et al
    Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Nephrol Dial Transplant. 2017 Feb 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. KABORE R, Haller MC, Harambat J, Heinze G, et al
    Risk prediction models for graft failure in kidney transplantation: a systematic review.
    Nephrol Dial Transplant. 2017 Feb 16. doi: 10.1093.
    PubMed     Text format    


  24. OBI Y, Kalantar-Zadeh K, Streja E, Rhee CM, et al
    Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  25. DOBROWOLSKI LC, van Huis M, van der Lee JH, Peters Sengers H, et al
    Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands.
    Nephrol Dial Transplant. 2017;32:402.
    PubMed     Text format    


    January 2017
  26. PIMENTEL AL, Cavagnolli G, Camargo JL
    Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis.
    Nephrol Dial Transplant. 2017 Jan 14. pii: gfw437. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. COUCHOUD C, Dantony E, Elsensohn MH, Villar E, et al
    Restricted mean survival time over 15 years for patients starting renal replacement therapy.
    Nephrol Dial Transplant. 2017 Jan 5. pii: gfw386. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. VAN DEN BRAND JA, Verhave JC, Adang EM, Wetzels JF, et al
    Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome.
    Nephrol Dial Transplant. 2017;32.
    PubMed     Text format     Abstract available


  29. LANTINGA MA, Casteleijn NF, Geudens A, de Sevaux RG, et al
    Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review.
    Nephrol Dial Transplant. 2017;32:144-150.
    PubMed     Text format     Abstract available


    December 2016
  30. PICHLER G, Haller MC, Kainz A, Wolf M, et al
    Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2016 Dec 26. pii: gfw387. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. ROZEN-ZVI B, Schneider S, Lichtenberg S, Green H, et al
    Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation.
    Nephrol Dial Transplant. 2016 Dec 26. pii: gfw394. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  32. BAMOULID J, Staeck O, Crepin T, Halleck F, et al
    Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  33. WEEKERS L, Vanderweckene P, Pottel H, Castanares-Zapatero D, et al
    The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  34. DELLO STROLOGO L, Murer L, Guzzo I, Morolli F, et al
    Renal transplantation in sensitized children and young adults: a nationwide approach.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


    September 2016
  35. ENGBERG H, Wehberg S, Bistrup C, Heaf J, et al
    Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


    July 2016
  36. REDFIELD RR, Scalea JR, Zens TJ, Mandelbrot DA, et al
    The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  37. HALLECK F, Khadzhynov D, Liefeldt L, Schrezenmeier E, et al
    Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


    June 2016
  38. HUBER M, Kemmner S, Renders L, Heemann U, et al
    Should belatacept be the centrepiece of renal transplantation?
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  39. DOBROWOLSKI LC, van Huis M, van der Lee JH, Peters Sengers H, et al
    Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


    May 2016
  40. OPELZ G, Unterrainer C, Susal C, Dohler B, et al
    Efficacy and safety of antibody induction therapy in the current era of kidney transplantation.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  41. OPELZ G, Unterrainer C, Susal C, Dohler B, et al
    Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  42. LADHANI M, Craig JC, Irving M, Clayton PA, et al
    Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


    April 2016
  43. LACHMANN N, Schonemann C, El-Awar N, Everly M, et al
    Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  44. HANSEN D, Olesen JB, Gislason GH, Abrahamsen B, et al
    Risk of fracture in adults on renal replacement therapy: a Danish national cohort study.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  45. GALLE JC, Addison J, Suranyi MG, Claes K, et al
    Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  46. VANHOLDER R, Glorieux G, Massy ZA
    Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations?
    Nephrol Dial Transplant. 2016.
    PubMed     Text format    


    March 2016
  47. PUELLES VG, Kanzaki G, Bertram JF
    Indirect estimation of nephron number: a new tool to predict outcomes in renal transplantation?
    Nephrol Dial Transplant. 2016.
    PubMed     Text format    


  48. SEVER MS, Goral S
    Kidney transplantation due to medical urgency: time for reconsideration?
    Nephrol Dial Transplant. 2016.
    PubMed     Text format    


  49. SCHWAIGER E, Eskandary F, Kozakowski N, Bond G, et al
    Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  50. LEE J, Lee JG, Kim S, Song SH, et al
    The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  51. POESEN R, Evenepoel P, de Loor H, Bammens B, et al
    The influence of renal transplantation on retained microbial-human co-metabolites.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  52. PORRINI EL, Diaz JM, Moreso F, Delgado Mallen PI, et al
    Clinical evolution of post-transplant diabetes mellitus.
    Nephrol Dial Transplant. 2016;31:495-505.
    PubMed     Text format     Abstract available


  53. LUQUE Y, Jamme M, Rabant M, DeWolf S, et al
    Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function.
    Nephrol Dial Transplant. 2016;31:487-95.
    PubMed     Text format     Abstract available


    February 2016
  54. ASSFALG V, Huser N, van Meel M, Haller B, et al
    High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  55. PINTER J, Hanson CS, Craig JC, Chapman JR, et al
    'I feel stronger and younger all the time'-perspectives of elderly kidney transplant recipients: thematic synthesis of qualitative research.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


    January 2016
  56. PECOITS-FILHO R, Calice-Silva V
    Unchain the heart: impact of left ventricular myocardial hypertrophy regression in kidney transplant outcomes.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format    


  57. MASSART A, Pallier A, Pascual J, Viklicky O, et al
    The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  58. SCHACHTNER T, Zaks M, Kahl A, Reinke P, et al
    Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  59. SANCHEZ-ZAPARDIEL E, Castro-Panete MJ, Mancebo E, Morales P, et al
    Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity.
    Nephrol Dial Transplant. 2016;31:150-60.
    PubMed     Text format     Abstract available


    November 2015
  60. PERASAARI JP, Kyllonen LE, Salmela KT, Merenmies JM, et al
    Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  61. ZSCHIEDRICH S, Janigen B, Dimova D, Neumann A, et al
    One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  62. O'SHAUGHNESSY MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC, et al
    Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  63. PAPE L, Tonshoff B, Hirsch HH
    Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  64. FERRARI P
    Nurturing the benefits of pre-emptive kidney transplantation.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format    


    September 2015
  65. EIDE IA, Jenssen T, Hartmann A, Diep LM, et al
    Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  66. SEVER MS, Zoccali C
    Moderator's view: Pretransplant weight loss in dialysis patients: cum grano salis.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format    


  67. DANOVITCH GM, Delmonico FL
    A path of hope for organ transplantation in China?
    Nephrol Dial Transplant. 2015;30:1413-4.
    PubMed     Text format    


  68. XIAOMING P, Xiang H, LinJuan L, Chenguang D, et al
    Preliminary results of transplantation with kidneys donated after cardiac death: a path of hope for organ transplantation in China.
    Nephrol Dial Transplant. 2015;30:1590-6.
    PubMed     Text format     Abstract available


    August 2015
  69. VAN DE LUIJTGAARDEN MW, Jager KJ, Segelmark M, Pascual J, et al
    Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  70. FERRARI P, Weimar W, Johnson RJ, Lim WH, et al
    Kidney paired donation: principles, protocols and programs.
    Nephrol Dial Transplant. 2015;30:1276-85.
    PubMed     Text format     Abstract available


  71. LEE AP, Abramowicz D
    Is the Kidney Donor Risk Index a step forward in the assessment of deceased donor kidney quality?
    Nephrol Dial Transplant. 2015;30:1285-90.
    PubMed     Text format     Abstract available


    July 2015
  72. KOLONKO A, Chudek J, Wiecek A
    Initial kidney graft resistance index and the long-term cardiovascular mortality in transplanted patients: a paired grafts analysis.
    Nephrol Dial Transplant. 2015;30:1218-24.
    PubMed     Text format     Abstract available


    April 2015
  73. CHESNAYE NC, Schaefer F, Groothoff JW, Caskey FJ, et al
    Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: